BioSpace News Archive

TriSalus Life Sciences®, today highlighted a series of updates from clinical and pre-clinical studies that help support the company’s immunotherapy platform approach for treating liver and pancreatic tumors.

FUJIFILM Irvine Scientific, Inc. announced it has exclusively licensed the intellectual property relating to artificial intelligence for image-based evaluation of human embryos to improve in-vitro fertilization success rates.

The U.S. Continuous Renal Replacement Therapy Market size was valued at US$ 995.7 million in 2021 and is expected to hit US$ 1.2 Billion by 2030, growing at a compound annual growth rate (CAGR) of 7.9% from 2022 to 2030.

BioAxone BioSciences, Inc., a clinical stage biotechnology company committed to discovering and developing drugs for neurological conditions, today announced that a new patent has been issued for BA-210, a Phase 3-ready pro-regenerative drug candidate for the treatment of spinal cord injury.

Launch of Termeer Scholars Program Will Support Biomedical Researchers and Bring Emerging Talent into the Foundation’s Network of Biotech Innovators.

Following a recent funding round raising $6.1 million (NZD $8.8 million), biotech company Pictor today announced it has received confirmation of CE registration for its PictArray™ SARS-CoV-2 IgG enzyme-linked immunosorbent assay (ELISA) antibody test as per In Vitro Diagnostic Directive (IVDD) regulations.

Propanc Biopharma, Inc. today announced that the results from a small trial of just 18 rectal cancer patients in complete remission using an immunotherapy called dostarlimab are “impressive,” whilst acknowledging there’s more work to be done.

SIGA Technologies, Inc. announced that its Chief Executive Officer, Phil Gomez, and Chief Scientific Officer, Dennis Hruby, will be participating in a panel on Thursday, June 23rd at 12pm ET to discuss the recent outbreaks of monkeypox in the U.K., EU, and U.S.

A team of investigators from Texas Heart Institute, Texas Children’s Hospital and Baylor College of Medicine uncovered new insights into the mechanisms underlying the progression of congenital heart disease (CHD) ― a spectrum of heart defects that develop before birth and remain the leading cause of childhood death.